In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis

Diagnostic Microbiology and Infectious Disease

Volumn 42, Issue 2, 2002, Pages 113-118

  Goldstein, Ellie J C ^a,b   Conrads, Georg ^a,c   Citron, Diane M ^a   Merriam, C Vreni ^a   Warren, Yumi ^a   Tyrrell, Kerin ^a  

^a Santa Monica UCLA Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFUROXIME; CLARITHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BACTEROIDES UNIFORMIS; BILOPHILA WADSWORTHIA; CONTROLLED STUDY; DILUTION; FUSOBACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA; NONHUMAN; PEPTOSTREPTOCOCCUS; PREVOTELLA; PREVOTELLA BIVIA; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SINUSITIS; STRAIN DIFFERENCE; VEILLONELLA;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MAXILLARY SINUS; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; PUNCTURES; SINUSITIS;

EID: 0036178559     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00341-8     Document Type: Article

References (24)

1. Bacteriology and β-lactamase activity in acute and chronic maxillary sinusitis
2. Microbiology of the transition from acute to chronic maxillary sinusitis
3. Resistance to antimicrobials used for therapy of otitis media and sinusitis: Effect of previous antimicrobial therapy and smoking
4. Medical management of acute bacterial sinusitis: Recommendations of a clinical advisory committee on pediatric and adult sinusitis
5. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during winter months of 1994 to 1995: Results of a 30-center national surveillance study
6. Comparative in vitro activity of gemifloxacin and other quinolones against maxillary sinus pathogens
7. Review of the in vitro activity of gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens
8. Gemifloxacin [SB 26805] compared to other oral antimicrobials agents against unusual anaerobes
9. In vitro activity of gemifloxacin [SB 26805] against anaerobes
10. Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro
11. Bacteriological findings of acute maxillary sinusitis in young adults
12. The comparative in vitro activity of gemifloxacin, a novel fluoroquinolone, against selected clinical isolates
13. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA
14. Purification of pneumococcal type II topoisomerase and inhibition by gemifloxacin and other quinolones
15. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae
16. In vitro activity of gemifloxacin and other antimicrobial agents against isolates of Bordetella pertussis and Bordetella parapertussis
17. Gram-positive anaerobic cocci
18. Antimicrobial resistance in anaerobes
19. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis
20. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus pneumoniae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season